Petmed Express Inc (NASDAQ:PETS) shares gapped up prior to trading on Monday . The stock had previously closed at $15.90, but opened at $19.44. Petmed Express shares last traded at $26.05, with a volume of 7,580,622 shares traded.

A number of analysts recently issued reports on PETS shares. Craig Hallum raised their price target on Petmed Express from $15.00 to $20.00 and gave the stock a “hold” rating in a research report on Thursday. ValuEngine upgraded Petmed Express from a “sell” rating to a “hold” rating in a research report on Wednesday, October 2nd. Finally, BidaskClub upgraded Petmed Express from a “sell” rating to a “hold” rating in a research report on Thursday, August 1st.

The business has a 50 day simple moving average of $17.97 and a two-hundred day simple moving average of $18.06. The firm has a market cap of $403.70 million, a PE ratio of 13.52 and a beta of 0.57.

Petmed Express (NASDAQ:PETS) last released its earnings results on Monday, July 22nd. The company reported $0.26 earnings per share for the quarter, missing analysts’ consensus estimates of $0.42 by ($0.16). Petmed Express had a return on equity of 23.42% and a net margin of 11.05%. The business had revenue of $79.99 million during the quarter, compared to analysts’ expectations of $85.83 million. During the same quarter in the previous year, the business earned $0.62 EPS. The business’s revenue for the quarter was down 8.5% on a year-over-year basis.

A number of hedge funds have recently added to or reduced their stakes in the business. Tyers Asset Management LLC increased its stake in Petmed Express by 20.7% in the second quarter. Tyers Asset Management LLC now owns 4,356 shares of the company’s stock worth $68,000 after purchasing an additional 748 shares during the period. Charles Schwab Investment Management Inc. increased its stake in Petmed Express by 0.7% in the second quarter. Charles Schwab Investment Management Inc. now owns 114,919 shares of the company’s stock worth $1,801,000 after purchasing an additional 767 shares during the period. Riverhead Capital Management LLC increased its stake in Petmed Express by 19.4% in the second quarter. Riverhead Capital Management LLC now owns 4,917 shares of the company’s stock worth $77,000 after purchasing an additional 800 shares during the period. Flinton Capital Management LLC increased its stake in Petmed Express by 20.7% in the second quarter. Flinton Capital Management LLC now owns 5,544 shares of the company’s stock worth $87,000 after purchasing an additional 952 shares during the period. Finally, Neuburgh Advisers LLC increased its stake in Petmed Express by 20.7% in the second quarter. Neuburgh Advisers LLC now owns 6,732 shares of the company’s stock worth $105,000 after purchasing an additional 1,156 shares during the period. Institutional investors and hedge funds own 97.46% of the company’s stock.

About Petmed Express (NASDAQ:PETS)

PetMed Express, Inc and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. It markets prescription and non-prescription pet medications, and other health products for dogs and cats directly to the consumers. The company offers non-prescription medications and supplies, including flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, such as heartworm preventative, flea and tick preventative, arthritis, thyroid, diabetes, pain, heart/blood pressure, and other specialty medications, as well as generic substitutes.

Featured Article: How is the LIBOR rate calculated?

Receive News & Ratings for Petmed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Petmed Express and related companies with MarketBeat.com's FREE daily email newsletter.